Further evidence supports no link between vaccination and MS

A new study published this week in the prestigious journal JAMAconfirms that vaccination for human papillomavirus (HPV) does not increase the risk of developing MS or other demyelinating disorders. This analysis was conducted in a population study of almost 4 million girls and women from Denmark and Sweden, of whom almost 800 000 received the vaccine between 2006 and 2013.

A possible link between vaccination and the risk of MS has been controversial for some time, however, a growing number of studies are providing high quality evidence to refute this link. MS Research Australia recently reported on a large US study that came to the same conclusion in November last year.

This new study, led by researchers from the Statens Serum Institute in Denmark and the Karolinska Institute in Sweden, provides gold standard evidence from data collected via routine nationwide registers of unselected populations in two countries. The HPV vaccine was licensed in 2006 for wide-scale dissemination to all females to protect against the papillomavirus infection that contributes to the development of cervical cancer.

The authors suggest that there is no evidence for a causal relationship between HPV vaccination and demyelinating disorders, and do not recommend any changes to current vaccination policy.


Proposed NDIS Improvements Promise to Enhance Support for People with MS

Promising developments were announced recently that could significantly elevate the...

ATA188 and the Quest for Progressive MS Treatment

ATA188, a therapy aiming to retrain T-cells to combat EBV...

Want us to keep you in the loop? Subscribe today!

  • Enter your details

Read More

Newsletter subscription

  • Enter your details

Further evidence supports no link between vaccination and MS